Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Involvement of IL-4, IL-13 and Their Receptors in Pancreatic Cancer
Jingwei Shi, Xujun Song, Benno Traub, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2998-2998
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Macrophages at the interface of the co-evolving cancer ecosystem
Daan J. Kloosterman, Leila Akkari
Cell (2023) Vol. 186, Iss. 8, pp. 1627-1651
Open Access | Times Cited: 179
Evaluation of the association of chronic inflammation and cancer: Insights and implications
Manisha Nigam, Abhay Prakash Mishra, Vishal Kumar Deb, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 115015-115015
Open Access | Times Cited: 83
Cutaneous T‐cell lymphoma following dupilumab use: a systematic review
Ariel Park, Lulu Wong, Annalise Lang, et al.
International Journal of Dermatology (2022) Vol. 62, Iss. 7, pp. 862-876
Open Access | Times Cited: 40
Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review
Rexiati Ruze, Jianlu Song, Xinpeng Yin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 38
The application of Interleukin-2 family cytokines in tumor immunotherapy research
Yangyihua Zhou, Guiqi Quan, Yujun Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs
Shengwen Shao, Huilai Miao, Wenxue Ma
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates
Candace L. Haddox, Michael J. Nathenson, Emanuele Mazzola, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 7, pp. 1281-1292
Open Access | Times Cited: 11
Mechanism and strategies of immunotherapy resistance in colorectal cancer
Jiqi Shan, Dong Han, Chunyi Shen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring
Sajida Maryam, Katarzyna Krukiewicz, Ihtisham Ul Haq, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3127-3127
Open Access | Times Cited: 16
IL-13/IL-13RA2 signaling promotes colorectal cancer stem cell tumorigenesis by inducing ubiquitinated degradation of p53
Baoyu He, Jing Liang, Qianqian Qin, et al.
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 495-508
Open Access | Times Cited: 15
Extracellular vesicles secreted by 3D tumor organoids are enriched for immune regulatory signaling biomolecules compared to conventional 2D glioblastoma cell systems
Martina Schuster, Frank Braun, Dapi Menglin Chiang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases
Jolanta Pach, Kailyn Valido, Annika Belzer, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 4, pp. 595-607
Closed Access | Times Cited: 5
Based on the immune system: the role of the IL-2 family in pancreatic disease
Yuqing Zhu, Zheng Lu, Zhuo Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Cellular morphometry of the neoplastic microenvironment and its association with the immunoexpression of Interleukin-4
Caio Rodrigues Maia, Maria Sara Maia de Queiroz, Carlos Augusto Galvão Barboza, et al.
Tissue and Cell (2025) Vol. 95, pp. 102816-102816
Closed Access
Myeloid-derived suppressor cells in metabolic and cardiovascular disorders
Jingsheng Yan, Shuai Guo, Jun He, et al.
Trends in Endocrinology and Metabolism (2025)
Closed Access
Deciphering T-cell exhaustion in the tumor microenvironment: paving the way for innovative solid tumor therapies
Reshmi S. Nair, Veena Somasundaram, Anshu Kuriakose, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The tumor immune-microenvironment in gastric cancer
Fujin Fang, Tiantian Zhang, Qiong Li, et al.
Tumori Journal (2022) Vol. 108, Iss. 6, pp. 541-551
Closed Access | Times Cited: 21
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer
Geny Piro, Carmine Carbone, Antonio Agostini, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 2, pp. 331-341
Open Access | Times Cited: 21
Engineered macrophages acting as a trigger to induce inflammation only in tumor tissues
Kenta Tanito, Teruki Nii, Yuta Yokoyama, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 885-895
Open Access | Times Cited: 11
The effectiveness of blood-activating and stasis-transforming traditional Chinese medicines (BAST) in lung cancer progression-a comprehensive review
Siqi Wu, Zhe Sun, Zehuai Guo, et al.
Journal of Ethnopharmacology (2023) Vol. 314, pp. 116565-116565
Closed Access | Times Cited: 10
Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential
Eric Jou
Exploration of Targeted Anti-tumor Therapy (2023), pp. 474-497
Open Access | Times Cited: 10
Lactococcus lactis as an Interleukin Delivery System for Prophylaxis and Treatment of Inflammatory and Autoimmune Diseases
Gabriela Munis Campos, Monique Ferrary Américo, Andria dos Santos Freitas, et al.
Probiotics and Antimicrobial Proteins (2023) Vol. 16, Iss. 2, pp. 352-366
Open Access | Times Cited: 9
The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets
Alba Guglielmo, Corrado Zengarini, Claudio Agostinelli, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 584-584
Open Access | Times Cited: 3
Good CARMA: Turning bad tumor‐resident myeloid cells good with chimeric antigen receptor macrophages
Christopher M. Snyder, Saar Gill
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 236-249
Closed Access | Times Cited: 7
Induction of pancreatic neoplasia in the KRAS/TP53 Oncopig
Pinaki Mondal, Neesha Patel, Katie Bailey, et al.
Disease Models & Mechanisms (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top